<?xml version='1.0' encoding='UTF-8'?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-03-13T01:10:50Z</responseDate>
  <request identifier="oai:fukuyama-u.repo.nii.ac.jp:00008818" verb="GetRecord" metadataPrefix="oai_dc">https://fukuyama-u.repo.nii.ac.jp/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:fukuyama-u.repo.nii.ac.jp:00008818</identifier>
        <datestamp>2023-06-19T10:16:14Z</datestamp>
        <setSpec>502:503:627:779</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns="http://www.w3.org/2001/XMLSchema" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>転移性乳癌患者における、エイコサペンタエン酸(EPA)強化濃厚流動食投与のおよぼす効果(発表論文抄録(2011))</dc:title>
          <dc:title>Effect of an eicosapentaenoic acid (EPA)-containing oral nutritional supplement in metastatic breast cancer patients</dc:title>
          <dc:creator>三好, 和也</dc:creator>
          <dc:creator>46137</dc:creator>
          <dc:creator>森田, 哲生</dc:creator>
          <dc:creator>46138</dc:creator>
          <dc:creator>大浜, 修</dc:creator>
          <dc:creator>46139</dc:creator>
          <dc:creator>野村, 長久</dc:creator>
          <dc:creator>46140</dc:creator>
          <dc:subject>エイコサペンタエン酸)</dc:subject>
          <dc:subject>乳癌</dc:subject>
          <dc:subject>レプチン</dc:subject>
          <dc:subject>EPA (eicosapentaenoic acid)</dc:subject>
          <dc:subject>breast cancer</dc:subject>
          <dc:subject>leptin</dc:subject>
          <dc:description>departmental bulletin paper</dc:description>
          <dc:publisher>福山大学薬学部</dc:publisher>
          <dc:date>2012-12-25</dc:date>
          <dc:format>application/pdf</dc:format>
          <dc:identifier>福山大学薬学部研究年報</dc:identifier>
          <dc:identifier>30</dc:identifier>
          <dc:identifier>14</dc:identifier>
          <dc:identifier>14</dc:identifier>
          <dc:identifier>Annual report of the Faculty of Pharmacy &amp; Pharmaceutical Sciences, Fukuyama University</dc:identifier>
          <dc:identifier>AN10064550</dc:identifier>
          <dc:identifier>0288-724X</dc:identifier>
          <dc:identifier>https://fukuyama-u.repo.nii.ac.jp/record/8818/files/30-14.pdf</dc:identifier>
          <dc:identifier>https://fukuyama-u.repo.nii.ac.jp/records/8818</dc:identifier>
          <dc:language>jpn</dc:language>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
